Holen Sie sich die Stockscreener-App
7.38
1.93%
0.14
Handel nachbörslich:
7.31
-0.07
-0.95%
Schlusskurs vom Vortag:
$7.24
Offen:
$7.25
24-Stunden-Volumen:
655.64K
Relative Volume:
0.65
Marktkapitalisierung:
$642.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-69.31M
KGV:
-5.811
EPS:
-1.27
Netto-Cashflow:
$-62.80M
1W Leistung:
+2.22%
1M Leistung:
+25.08%
6M Leistung:
+83.58%
1J Leistung:
+57.02%
1-Tages-Spanne:
$7.145
$7.45
1-Wochen-Bereich:
$6.92
$7.45
52-Wochen-Spanne:
$2.215
$7.4578
Rezolute Inc Stock (RZLT) Company Profile
Firmenname
Rezolute Inc
Sektor
Branche
Telefon
650-206-4507
Adresse
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Vergleichen Sie RZLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
7.38 | 623.76M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Eingeleitet | Wedbush | Outperform |
| 2024-08-27 | Eingeleitet | Guggenheim | Buy |
| 2024-07-17 | Eingeleitet | BTIG Research | Buy |
| 2024-06-04 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-09 | Eingeleitet | Maxim Group | Buy |
| 2022-08-02 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-27 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Rezolute Inc Aktie (RZLT) Neueste Nachrichten
Price action breakdown for Rezolute Inc.2025 Biggest Moves & Community Trade Idea Sharing Platform - Newser
Rezolute stock rating reiterated at Buy by H.C. Wainwright on FDA study approval - Investing.com Australia
Short interest data insights for Rezolute Inc.Trade Entry Report & Step-by-Step Swing Trade Plans - Newser
Volume spikes in Rezolute Inc. stock – what they meanJobs Report & AI Forecast Swing Trade Picks - Newser
Using data models to predict Rezolute Inc. stock movementPortfolio Value Summary & Daily Entry Point Alerts - Newser
Trend analysis for Rezolute Inc. this weekGap Down & Reliable Price Breakout Signals - Newser
What chart patterns are forming on Rezolute Inc.July 2025 Rallies & Expert Approved Momentum Ideas - khodrobank.com
Can a trend reversal in Rezolute Inc. lead to recoveryWeekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
Applying Elliott Wave Theory to Rezolute Inc.Market Sentiment Report & AI Forecast for Swing Trade Picks - Newser
Chart overlay techniques for tracking Rezolute Inc.Portfolio Value Report & Intraday High Probability Setup Alerts - Newser
Should you hold or exit Rezolute Inc. nowJuly 2025 Market Mood & Safe Swing Trade Setups - Newser
Rezolute Inc. stock trend outlook and recovery pathJuly 2025 Earnings & Verified High Yield Trade Plans - Newser
Will Rezolute Inc. see short term momentumJuly 2025 Recap & AI Powered Buy and Sell Recommendations - Newser
What is the long term forecast for Rezolute Inc. stockJuly 2025 Final Week & Weekly Stock Breakout Alerts - khodrobank.com
Combining price and volume data for Rezolute Inc.2025 Performance Recap & Accurate Entry and Exit Point Alerts - Newser
Is it too late to sell Rezolute Inc.Long Setup & Free Technical Confirmation Trade Alerts - Newser
Candlestick Signal Suggests Reversal in Rezolute Inc.2025 Volume Leaders & High Conviction Investment Ideas - Newser
Leading vs lagging indicators on Rezolute Inc. performanceQuarterly Trade Summary & Capital Efficiency Focused Ideas - Newser
Should value investors consider Rezolute Inc.Portfolio Update Report & Fast Exit Strategy with Risk Control - khodrobank.com
Does Rezolute Inc. qualify in momentum factor screeningJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser
Rezolute announces alignment with FDA on streamlined design for ongoing phase 3 trial of ersodetug in tumor hyperinsulinism - MarketScreener
Can Rezolute Inc. recover in the next quarterJuly 2025 Recap & AI Powered Buy and Sell Recommendations - Newser
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism - The Manila Times
Rezolute Aligns with FDA on Phase 3 Trial Design - TipRanks
Rezolute Announces FDA Alignment for Ersodetug Phase 3 Trial in Tumor HI. - AInvest
Applying sector rotation models to Rezolute Inc.Weekly Volume Report & Safe Entry Point Alerts - Newser
Can Rezolute Inc. lead its sector in growthJuly 2025 Big Picture & Reliable Volume Spike Alerts - khodrobank.com
Will Rezolute Inc. stock go up in YEARJuly 2025 Weekly Recap & Weekly Top Performers Watchlists - khodrobank.com
Is Rezolute Inc. stock bottoming outEarnings Overview Summary & AI Powered Market Entry Ideas - Newser
What is Rezolute Inc.’s book value per shareJuly 2025 Action & Free High Accuracy Swing Entry Alerts - khodrobank.com
What’s the RSI of Rezolute Inc. stockWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - khodrobank.com
Sentiment Watch: How does Rezolute Inc. compare to its peers2025 Momentum Check & Real-Time Buy Signal Alerts - khodrobank.com
Backtesting results for Rezolute Inc. trading strategiesJuly 2025 Patterns & Daily Technical Stock Forecast Reports - Newser
What is Rezolute Inc. s debt to equity ratioJuly 2025 Pullbacks & Smart Allocation Stock Reports - khodrobank.com
Has Rezolute Inc. found a price floorWeekly Stock Summary & Consistent Income Trade Recommendations - Newser
Published on: 2025-09-01 14:45:41 - Newser
Is Rezolute Inc. a stock for growth or value investors2025 Market Overview & Community Verified Swing Trade Signals - khodrobank.com
Can Rezolute Inc. hit a new high this month2025 Market WrapUp & Daily Profit Maximizing Trade Tips - Newser
Will Rezolute Inc. continue its uptrendGap Up & Free High Accuracy Swing Entry Alerts - Newser
Published on: 2025-09-01 03:56:37 - Newser
Is Rezolute Inc. backed by strong institutional buying2025 Major Catalysts & Advanced Swing Trade Entry Plans - khodrobank.com
Detecting support and resistance levels for Rezolute Inc.Chart Signals & Weekly Top Stock Performers List - Newser
Signal strength of Rezolute Inc. stock in tech scanners2025 Support & Resistance & Consistent Profit Alerts - Newser
Visualizing Rezolute Inc. stock with heatmapsQuarterly Earnings Report & Safe Entry Point Alerts - Newser
Is it time to cut losses on Rezolute Inc.Weekly Trend Recap & Technical Analysis for Trade Confirmation - Newser
Sector ETF performance correlation with Rezolute Inc.Forecast Cut & Daily Technical Forecast Reports - Newser
Can Rezolute Inc. rally from current levelsEarnings Growth Summary & Growth-Oriented Investment Plans - Newser
Why Rezolute Inc. is moving today2025 Fundamental Recap & High Accuracy Swing Trade Signals - Newser
Using economic indicators to assess Rezolute Inc. potential2025 Winners & Losers & Daily Profit Focused Screening - Newser
Finanzdaten der Rezolute Inc-Aktie (RZLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rezolute Inc-Aktie (RZLT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO |
Jun 24 '25 |
Buy |
4.05 |
5,000 |
20,250 |
268,900 |
| Kim Young-Jin | Director |
Jun 13 '25 |
Buy |
3.25 |
1,230,769 |
3,999,999 |
8,423,386 |
| KREHER NERISSA | Director |
Jun 13 '25 |
Buy |
3.25 |
3,076 |
9,997 |
37,576 |
| Hogenhuis Wladimir | Director |
Mar 31 '25 |
Buy |
2.92 |
6,758 |
19,733 |
84,025 |
| Elam Nevan C | CEO |
Mar 27 '25 |
Buy |
2.85 |
12,302 |
34,999 |
224,119 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.89 |
10,000 |
28,900 |
237,900 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.88 |
10,000 |
28,800 |
23,000 |
| Hogenhuis Wladimir | Director |
Feb 18 '25 |
Buy |
4.70 |
10,000 |
47,000 |
77,267 |
| Evans Daron | CFO |
Dec 18 '24 |
Buy |
4.29 |
10,000 |
42,900 |
150,900 |
| Evans Daron | CFO |
Dec 12 '24 |
Buy |
4.60 |
9,000 |
41,400 |
140,900 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):